Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Nov 06, 2006	SCHLEIFER LEONARD S Director, Chief Exec Officer & President, Ten Percent Owner	Director, Chief Exec Officer & President, Ten Percent Owner	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	122,630	--	37,370
Dec 15, 2016	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	122,032	$380.09	157,409
Dec 13, 2017	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	121,586	$385.08	271,593
Sep 18, 2013	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	108,632	$304.38	145,036
Dec 12, 2019	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	97,209	$377.16	474,499
May 11, 2020	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	96,947	$571.43	625,421
Dec 13, 2018	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	96,079	$377.31	363,014
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	95,429	$111.01	267,775
Feb 14, 2012	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	95,016	$111.01	379,002
Aug 06, 2021	SCHLEIFER LEONARD S Director, President & CEO	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	91,430	$607.51	504,746

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media